{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:13:31Z","timestamp":1793823211559,"version":"4.6.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T00:00:00Z","timestamp":1514332800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1208\/s12248-017-0179-0","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T19:25:32Z","timestamp":1514402732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling"],"prefix":"10.1208","volume":"20","author":[{"given":"Qianwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ho","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.Y.","family":"Edwin Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"issue":"7","key":"179_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614\u201328. https:\/\/doi.org\/10.1016\/j.addr.2011.11.002 .","journal-title":"Adv Drug Deliv Rev"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jpba.2011.11.025","volume":"61","author":"S Qian","year":"2012","unstructured":"Qian S, Wo SK, Zuo Z. Pharmacokinetics and brain dispositions of tacrine and its major bioactive monohydroxylated metabolites in rats. J Pharm Biomed Anal. 2012;61:57\u201363. https:\/\/doi.org\/10.1016\/j.jpba.2011.11.025 .","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"179_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"J Freiherr","year":"2013","unstructured":"Freiherr J, Hallschmid M, Frey WH II, Br\u00fcnner YF, Chapman CD, H\u00f6lscher C, et al. Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS drugs. 2013;27(7):505\u201314. https:\/\/doi.org\/10.1007\/s40263-013-0076-8 .","journal-title":"CNS drugs"},{"issue":"2","key":"179_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","volume":"127","author":"R Thorne","year":"2004","unstructured":"Thorne R, Pronk G, Padmanabhan V, Frey W II. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127(2):481\u201396. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.05.029 .","journal-title":"Neuroscience"},{"issue":"6","key":"179_CR5","first-page":"418","volume":"2","author":"R Draghia","year":"1995","unstructured":"Draghia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L. Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther. 1995;2(6):418\u201323.","journal-title":"Gene Ther"},{"issue":"6","key":"179_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","volume":"88","author":"L Danielyan","year":"2009","unstructured":"Danielyan L, Sch\u00e4fer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, Klopfer T, et al. Intranasal delivery of cells to the brain. Eur J Cell Biol. 2009;88(6):315\u201324. https:\/\/doi.org\/10.1016\/j.ejcb.2009.02.001 .","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"179_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1023\/A:1007542618378","volume":"17","author":"M Dahlin","year":"2000","unstructured":"Dahlin M, Bergman U, Jansson B, Bj\u00f6rk E, Brittebo E. Transfer of dopamine in the olfactory pathway following nasal administration in mice. Pharm Res. 2000;17(6):737\u201342. https:\/\/doi.org\/10.1023\/A:1007542618378 .","journal-title":"Pharm Res"},{"issue":"3","key":"179_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2165\/00126839-200506030-00002","volume":"6","author":"A Wall","year":"2005","unstructured":"Wall A, K\u00e5gedal M, Bergstr\u00f6m M, Jacobsson E, Nilsson D, Antoni G, et al. Distribution of zolmitriptan into the CNS in healthy volunteers. Drugs in R & D. 2005;6(3):139\u201347. https:\/\/doi.org\/10.2165\/00126839-200506030-00002 .","journal-title":"Drugs in R & D"},{"issue":"4","key":"179_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00005072-199407000-00009","volume":"53","author":"LC Walker","year":"1994","unstructured":"Walker LC, Price DL, Voytko ML, Schenk DB. Labeling of cerebral amyloid in vivo with a monoclonal antibody. J Neuropathol Exp Neurol. 1994;53(4):377\u201383. https:\/\/doi.org\/10.1097\/00005072-199407000-00009 .","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"179_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10717544.2013.838713","volume":"21","author":"D Mittal","year":"2014","unstructured":"Mittal D, Ali A, Md S, Baboota S, Sahni JK, Ali J. Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv. 2014;21(2):75\u201386. https:\/\/doi.org\/10.3109\/10717544.2013.838713 .","journal-title":"Drug Deliv."},{"issue":"1","key":"179_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3\u201314. https:\/\/doi.org\/10.1602\/neurorx.2.1.3 .","journal-title":"NeuroRx"},{"issue":"8","key":"179_CR12","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1128\/JVI.02453-08","volume":"83","author":"D Kugel","year":"2009","unstructured":"Kugel D, Kochs G, Obojes K, Roth J, Kobinger GP, Kobasa D, et al. Intranasal administration of alpha interferon reduces seasonal influenza a virus morbidity in ferrets. J Virol. 2009;83(8):3843\u201351. https:\/\/doi.org\/10.1128\/JVI.02453-08 .","journal-title":"J Virol"},{"issue":"2","key":"179_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/10611869909085497","volume":"7","author":"C Eriksson","year":"1999","unstructured":"Eriksson C, Bergman U, Franzen A, Sj\u00f6blom M, Brittebo E. Transfer of some carboxylic acids in the olfactory system following intranasal administration. J Drug Target. 1999;7(2):131\u201342. https:\/\/doi.org\/10.3109\/10611869909085497 .","journal-title":"J Drug Target"},{"issue":"3","key":"179_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11095-006-9534-z","volume":"23","author":"UE Westin","year":"2006","unstructured":"Westin UE, Bostr\u00f6m E, Gr\u00e5sj\u00f6 J, Hammarlund-Udenaes M, Bj\u00f6rk E. Direct nose-to-brain transfer of morphine after nasal administration to rats. Pharm Res. 2006;23(3):565\u201372. https:\/\/doi.org\/10.1007\/s11095-006-9534-z .","journal-title":"Pharm Res"},{"key":"179_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","volume":"189","author":"L Kozlovskaya","year":"2014","unstructured":"Kozlovskaya L, Abou-Kaoud M, Stepensky D. Quantitative analysis of drug delivery to the brain via nasal route. J Control Release. 2014;189:133\u201340. https:\/\/doi.org\/10.1016\/j.jconrel.2014.06.053 .","journal-title":"J Control Release"},{"issue":"2","key":"179_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijpharm.2003.09.017","volume":"269","author":"MA Bagger","year":"2004","unstructured":"Bagger MA, Bechgaard EA. Microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug. Int J Pharm. 2004;269(2):311\u201322. https:\/\/doi.org\/10.1016\/j.ijpharm.2003.09.017 .","journal-title":"Int J Pharm"},{"issue":"2-3","key":"179_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ejps.2003.10.012","volume":"21","author":"MA Bagger","year":"2004","unstructured":"Bagger MA, Bechgaard E. The potential of nasal application for delivery to the central brain\u2014a microdialysis study of fluorescein in rats. Eur J Pharm Sci. 2004;21(2-3):235\u201342. https:\/\/doi.org\/10.1016\/j.ejps.2003.10.012 .","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"179_CR18","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s11095-008-9550-2","volume":"25","author":"ST Charlton","year":"2008","unstructured":"Charlton ST, Whetstone J, Fayinka ST, Read KD, Illum L, Davis SS. Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model. Pharm Res. 2008;25(7):1531\u201343. https:\/\/doi.org\/10.1007\/s11095-008-9550-2 .","journal-title":"Pharm Res"},{"issue":"5","key":"179_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1248\/bpb.34.740","volume":"34","author":"M Uchida","year":"2011","unstructured":"Uchida M, Katoh T, Mori M, Maeno T, Ohtake K, Kobayashi J, et al. Intranasal administration of milnacipran in rats: evaluation of the transport of drugs to the systemic circulation and central nervous system and the pharmacological effect. Biol Pharm Bull. 2011;34(5):740\u20137. https:\/\/doi.org\/10.1248\/bpb.34.740 .","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"179_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1742-7843.2009.00517.x","volume":"106","author":"M Hammarlund-Udenaes","year":"2010","unstructured":"Hammarlund-Udenaes M. Active-site concentrations of chemicals\u2013are they a better predictor of effect than plasma\/organ\/tissue concentrations? Basic Clin Pharmacol Toxicol. 2010;106(3):215\u201320. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00517.x .","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"179_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1124\/jpet.107.119560","volume":"323","author":"JC Kalvass","year":"2007","unstructured":"Kalvass JC, Olson ER, Cassidy MP, Selley DE, Pollack GM. Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data. J Pharmacol Exp Ther. 2007;323(1):346\u201355. https:\/\/doi.org\/10.1124\/jpet.107.119560 .","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"179_CR22","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1124\/dmd.111.040782","volume":"39","author":"J Stevens","year":"2011","unstructured":"Stevens J, Ploeger BA, van der Graaf PH, Danhof M, de Lange EC. Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administration. Drug Metab Dispos. 2011;39(12):2275\u201382. https:\/\/doi.org\/10.1124\/dmd.111.040782 .","journal-title":"Drug Metab Dispos"},{"key":"179_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jpba.2016.03.025","volume":"125","author":"Q Wang","year":"2016","unstructured":"Wang Q, Zhang Y, Qian S, Peng S, Zhang Q, Wong C, et al. Pharmacokinetics and brain uptake of HIV-1 replication inhibitor DB213 in Sprague-Dawley rats. J Pharm Biomed Anal. 2016;125:41\u20137. https:\/\/doi.org\/10.1016\/j.jpba.2016.03.025 .","journal-title":"J Pharm Biomed Anal"},{"key":"179_CR24","doi-asserted-by":"publisher","unstructured":"Guo Z, Hong Z, Dong W, Deng C, Zhao R, Xu J, et al. PM2. 5-induced oxidative stress and mitochondrial damage in the nasal mucosa of rats. Int J Environ Res Public Health. 2017;14(2):134. https:\/\/doi.org\/10.3390\/ijerph14020134.","DOI":"10.3390\/ijerph14020134"},{"key":"179_CR25","doi-asserted-by":"crossref","unstructured":"Yamamoto Y, V\u00e4litalo PA, van den Berg D, Hartman R, van den Brink W, Wong YC, et al. A generic multi-compartmental CNS distribution model structure for 9 drugs allows prediction of human brain target site concentrations. Pharm Res. 2016:1\u201319.","DOI":"10.1007\/s11095-016-2065-3"},{"issue":"8","key":"179_CR26","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s11095-014-1312-8","volume":"31","author":"YC Wong","year":"2014","unstructured":"Wong YC, Qian S, Zuo Z. Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery. Pharm Res. 2014;31(8):2107\u201323. https:\/\/doi.org\/10.1007\/s11095-014-1312-8 .","journal-title":"Pharm Res"},{"issue":"1","key":"179_CR27","first-page":"72","volume":"26","author":"HB Lee","year":"1985","unstructured":"Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med. 1985;26(1):72\u20136.","journal-title":"J Nucl Med"},{"issue":"8","key":"179_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0969-8051(99)00071-2","volume":"26","author":"D Stypinski","year":"1999","unstructured":"Stypinski D, Wiebe L, Tam Y, Mercer J, McEwan A. Effects of methoxyflurane anesthesia on the pharmacokinetics of 125 I-IAZA in sprague-dawley rats. Nucl Med Biol. 1999;26(8):959\u201365. https:\/\/doi.org\/10.1016\/S0969-8051(99)00071-2 .","journal-title":"Nucl Med Biol"},{"issue":"4","key":"179_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1124\/dmd.106.012294","volume":"35","author":"JC Kalvass","year":"2007","unstructured":"Kalvass JC, Maurer TS, Pollack GM. Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos. 2007;35(4):660\u20136. https:\/\/doi.org\/10.1124\/dmd.106.012294 .","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"179_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bdd.325","volume":"23","author":"J Cory Kalvass","year":"2002","unstructured":"Cory Kalvass J, Maurer TS. Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos. 2002;23(8):327\u201338. https:\/\/doi.org\/10.1002\/bdd.325 .","journal-title":"Biopharm Drug Dispos"},{"issue":"10","key":"179_CR31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0026-895X(24)12040-8","volume":"28","author":"E Brouwer","year":"2000","unstructured":"Brouwer E, Verweij J, De Bruijn P, Loos WJ, Pillay M, Buijs D, et al. Measurement of fraction unbound paclitaxel in human plasma. Drug Metab Dispos. 2000;28(10):1141\u20135.","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"179_CR32","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1124\/dmd.107.015222","volume":"35","author":"M Friden","year":"2007","unstructured":"Friden M, Gupta A, Antonsson M, Bredberg U, Hammarlund-Udenaes M. In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids. Drug Metab Dispos. 2007;35(9):1711\u20139. https:\/\/doi.org\/10.1124\/dmd.107.015222 .","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"179_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1124\/jpet.116.232702","volume":"358","author":"ME Modi","year":"2016","unstructured":"Modi ME, Majchrzak MJ, Fonseca KR, Doran A, Osgood S, Vanase-Frawley M, et al. Peripheral administration of a long-acting peptide oxytocin receptor agonist inhibits fear-induced freezing. J Pharmacol Exp Ther. 2016;358(2):164\u201372. https:\/\/doi.org\/10.1124\/jpet.116.232702 .","journal-title":"J Pharmacol Exp Ther"},{"key":"179_CR34","doi-asserted-by":"crossref","unstructured":"Hammarlund-Udenaes M. Pharmacokinetic concepts in brain drug delivery. In: Hammarlund-Udenaes M, de Lange E, Thorne RG, editors. Drug Delivery to the Brain. New York: Springer. 2014:127\u2013161.","DOI":"10.1007\/978-1-4614-9105-7_5"},{"issue":"1","key":"179_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1743-8454-5-10","volume":"5","author":"CE Johanson","year":"2008","unstructured":"Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal Fluid Res. 2008;5(1):10. https:\/\/doi.org\/10.1186\/1743-8454-5-10 .","journal-title":"Cerebrospinal Fluid Res"},{"issue":"2","key":"179_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143\u201351. https:\/\/doi.org\/10.1208\/s12248-011-9255-z .","journal-title":"AAPS J"},{"issue":"3","key":"179_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11481-010-9205-z","volume":"5","author":"KA Lindl","year":"2010","unstructured":"Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J NeuroImmune Pharmacol. 2010;5(3):294\u2013309. https:\/\/doi.org\/10.1007\/s11481-010-9205-z .","journal-title":"J NeuroImmune Pharmacol"},{"issue":"11","key":"179_CR38","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, et al. Controversies in HIV-associated neurocognitive disorders. Lancet Neurol. 2014;13(11):1139\u201351. https:\/\/doi.org\/10.1016\/S1474-4422(14)70137-1 .","journal-title":"Lancet Neurol"},{"issue":"20","key":"179_CR39","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1021\/jm901036q","volume":"52","author":"M Frid\u00e9n","year":"2009","unstructured":"Frid\u00e9n M, Winiwarter S, Jerndal G, Bengtsson O, Wan H, Bredberg U, et al. Structure\u2212 brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J Med Chem. 2009;52(20):6233\u201343. https:\/\/doi.org\/10.1021\/jm901036q .","journal-title":"J Med Chem"},{"key":"179_CR40","doi-asserted-by":"publisher","unstructured":"Terasaki T, Deguchi Y, Sato H, Hirai KI, Tsuji A. In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood\u2013brain barrier: an application of brain microdialysis. Pharm Res. 1991;8(7):815\u201320. https:\/\/doi.org\/10.1023\/A:1015882924470 .","DOI":"10.1023\/A:1015882924470"},{"issue":"3","key":"179_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10928-013-9301-9","volume":"40","author":"EC Lange de","year":"2013","unstructured":"de Lange EC. Utility of CSF in translational neuroscience. J Pharmacokinet Pharmacodyn. 2013;40(3):315\u201326. https:\/\/doi.org\/10.1007\/s10928-013-9301-9 .","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"179_CR42","doi-asserted-by":"crossref","unstructured":"Somjen GG. Ions and water in the brain. In: Somjen GG, editor. Ions in the brain: normal function, seizures, and stroke. Oxford: Oxford University Press. 2004:6\u20137.","DOI":"10.1093\/oso\/9780195151718.001.0001"},{"key":"179_CR43","doi-asserted-by":"publisher","unstructured":"Merkus FWHM, van den Berg MP. Can nasal drug delivery bypass the blood-brain barrier? Drugs R D. 2007;8(3):133\u201344. https:\/\/doi.org\/10.2165\/00126839-200708030-00001 .","DOI":"10.2165\/00126839-200708030-00001"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-017-0179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T07:57:58Z","timestamp":1751183878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-017-0179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1208\/s12248-017-0179-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]},"article-number":"23"}}